409 - 420 of 7695 results

FAQ for Breast Cancer Screening Updates

This talk will review current breast cancer screening guidelines. It will explain different modalities used to screen for breast cancer. Dr. Marcus will discuss factors to consider in initiating screening and when to stop routine screening for breast cancer. She will also talk about how to explain inconclusive findings and breast density to patients.Guest: Erin Marcus, MD, MPH

This talk will review current breast cancer screening guidelines. It will explain different modalities used to screen for breast cancer. Dr. Marcus will discuss factors to consider in initiating screening and when to stop routine screening for breast cancer. She will also talk about how to explain inconclusive findings and breast density to patients.


0.5 CME CREDIT

Get your questions answered by an expert faculty in Infectious Disease. You ask: we listen. You will learn practical solutions to common clinical challenges and tips to apply the latest knowledge in practice. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 7, 2020, and they are subject to change as new information is published.


This talk will review the pathophysiologic mechanisms of pain and how to best address them.


0.25 CME CREDIT

Through fifteen quick-hitting cases, this session will review select dermatologic rashes and neoplasms, both benign and malignant, that are commonly encountered by primary care physicians. Clinical descriptions of acne, alopecia areata, atopic dermatitis/eczema, lichen planus, pityriasis rosea, psoriasis, rosacea, seborrheic dermatitis, stasis dermatitis, tinea cruris/corporis/unguium, acrochordon, cherry angioma, seborrheic keratosis, actinic keratosis, basal cell carcinoma, squamous cell carcinoma, and melanoma are provided, followed by suggestions for treatment and management within the scope of primary care. Recommendations as to when to refer patients to Dermatology are noted. Reference atlas, textbook, website, and mobile application recommendations are also provided.


0.25 CME CREDIT

Lifestyle management has proven effective for addressing modifiable health risks, but can be challenging for patients to implement and maintain. This session will focus on wellness coaching as an important component of healthy living, both for patients and providers. Participants will learn about the benefits of engaging patients in health and wellness coaching, and will discuss strategies for incorporating this practice into their own patient care setting(s).


Coffee with Chopra: Episode 4
0.5 CME CREDIT

Join Dr. Sanjiv Chopra in this installment of Coffee with Chopra, as he interviews his guest, Dr. Melanie Hoenig, about advances in nephrology. In this session, the duo will discuss topics including: race and kidney function, HIV and HCV on kidney function, and the relationship between APOL1 and kidney failure.


FAQ for Primary Care Provider’s Guide to Autism

Many families worry about autism, even when their child’s development seems to be on track. Families also wonder about vaccine safety and hesitate to follow the recommended guidelines for vaccine administration. This interactive large-group session is designed to help primary care providers to understand whether there is an increase in autism, how to recognize autism in a primary care setting, where to refer, and how to discuss vaccine safety with families.Guest: Jeffrey P. Brosco, MD, PhD

Many families worry about autism, even when their child’s development seems to be on track. Families also wonder about vaccine safety and hesitate to follow the recommended guidelines for vaccine administration. This interactive large-group session is designed to help primary care providers to understand whether there is an increase in autism, how to recognize autism in a primary care setting, where to refer, and how to discuss vaccine safety with families.


FAQ for the Pharmacotherapy of Alcohol and Opioid Use Disorders

In the U.S., about 15.1 million people have an alcohol use disorder and about 4.8 million misuse opioids. This session focuses on the pharmacotherapy of alcohol and opioid use disorders. The faculty will describe and contrast naltrexone and acamprosate treatments for alcohol use disorder and discuss the use of buprenorphine/naloxone to treat opioid use disorder.Guest: Petros Levounis, MD, MA

In the U.S., about 15.1 million people have an alcohol use disorder and about 4.8 million misuse opioids. This session focuses on the pharmacotherapy of alcohol and opioid use disorders. The faculty will describe and contrast naltrexone and acamprosate treatments for alcohol use disorder and discuss the use of buprenorphine/naloxone to treat opioid use disorder.


FAQ for What's New in Obesity Management?

Guest: Robert F. Kushner, MD, FACP